$EIGR Stock Soar After Eiger’s Single-dose COVID-19 Reduced Risk of Hospitalization News
Eiger BioPharmaceuticals announced, “Peginterferon Lambda (Lambda) significantly reduced the risk of COVID-19-related hospitalizations or emergency room visits greater than six hours by 50% (primary endpoint) and death by 60% in the Phase 3 TOGETHER study, a multi-center, randomized, double-blind, placebo-controlled study of non-hospitalized adult patients with COVID-19, who are at high risk of progressing to severe illness.”
Wonder which online trading app would be easy and rewarding, also let you trade us pre market, day trading, Nasdaq index futures, and many more with an advanced trading chart? Join Moomoo and get up to 5 free stocks worth from $3 up to $3,500 each.
Sponsered: CapitalOne Silver Credit Card is giving a $200 sign-up bonus after you spend $500 in the first 3 months. This card is the most recommended for everyday spending, Earn unlimited 1.5% cash back on every purchase, with no annual fees. If you think you will spend $500 in 3 months, this might be a great card for you to start, and get that $200 sign-up bonus.